Pancreaze Capsule, Delayed Release
Product Images NDC 62541-406

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Pancreaze (NDC 62541-406). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Vivus Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Principal Display Panel (100 Capsule Bottle Carton)

Packaging label for PANCREAZE delayed-release capsules, pancrelipase containing 4,200 USP Units lipase, 24,600 USP Units amylase, and 14,200 USP Units protease per capsule. The label includes dosage storage instructions, manufacturing origin (Germany), manufacturer (VIVUS LLC), and a barcode. The package contains 100 capsules.*

FDA Label Image

Principal Display Panel (100 Capsule Bottle Carton)

Packaging label for PANCREAZE delayed-release capsules containing pancrelipase. It shows strength per capsule as 10,500 USP Units Lipase, 61,500 USP Units Amylase, and 35,500 USP Units Protease. The label states oral route, manufacturer VIVUS LLC, and includes handling/storage instructions, barcode, and 100 count package size.*

FDA Label Image

Principal Display Panel (100 Capsule Bottle Carton)

Packaging label for PANCREAZE delayed-release capsules by VIVUS LLC, featuring detailed information on composition and usage. The label highlights active enzyme units (Lipase 16,800 USP Units, Amylase 98,400 USP Units, Protease 56,800 USP Units) per capsule, dosage guidelines, storage instructions, and manufacturer details including production in Germany and labeling by VIVUS LLC. The label includes barcodes, lot, expiration, and serial number placeholders.*

FDA Label Image

Principal Display Panel (100 Capsule Bottle Carton)

The packaging label for PANCREAZE delayed-release capsules lists the active enzyme components per capsule as Lipase 21,000 USP Units, Amylase 83,900 USP Units, and Protease 54,700 USP Units. The label includes storage instructions, manufacturer details (VIVUS LLC and Nordmark Pharma GmbH), and indicates the product contains 100 capsules. The design features the PANCREAZE brand prominently on multiple panels along with dosage and pharmacist guidance.*

FDA Label Image

Principal Display Panel (100 Capsule Bottle Carton)

Packaging label for PANCREAZE delayed-release capsules containing pancrelipase. The label specifies lipase 2,600 USP units, amylase 15,200 USP units, and protease 8,800 USP units per capsule. The labeler is VIVUS LLC, with manufacturing by Nordmark Pharma GmbH in Germany. The package contains 100 capsules and includes prescribing information and storage instructions.*

FDA Label Image

Pancreaze 06

Packaging label for PANCREAZE delayed-release capsules containing pancreatic enzymes. Each capsule includes 37,000 USP Units of lipase, 149,900 USP Units of amylase, and 97,300 USP Units of protease. The label indicates a 100-count carton with storage and handling instructions, manufactured by VIVUS LLC in Germany. The label also includes prescription information, barcode, and areas reserved for lot number, expiration date, and serial number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.